In September 2014, we welcomed Hartford HealthCare Cancer Institute (HHCCI) — which comprises the five cancer programs of Hartford HealthCare’s multihospital system in Connecticut — as the first fully certified member in the Memorial Sloan Kettering Cancer Alliance.
Certification came after a year of intensive review and analysis of six disease specialties (breast, colorectal, kidney, lung, prostate, and uterine) and 11 disciplines across the institute. During that time, hundreds of experts and specialists from both organizations worked together to assess HHCCI’s resources and capabilities, and to develop plans to align on any gaps, with the ultimate goal of establishing a single, elevated standard of care across all five cancer programs.
Among the many distinctive aspects of the collaboration is the establishment of the first MSK Cancer Alliance clinical trials site. As of July 2015, two trials had opened with more in the pipeline. At least ten MSK trials are expected to be open to HHCCI patients by the close of 2015.
In addition, we are jointly recruiting a Physician-in-Chief of the Hartford Healthcare Cancer Institute who will be on staff at both HHCCI and Memorial Sloan Kettering. HHCCI doctors are actively working with our multidisciplinary disease management teams on standards of care, finding and developing areas of common research interest, and implementing clinical trials. And HHCCI nurses, pharmacists, imaging experts, and other care providers also underwent training.
As we continue to make progress together, HHCCI will be empowered to keep learning, adapting to, and adopting MSK’s standards of care within the context of its own institution and in the context of the communities it serves. Future projects include conducting joint quality and outcomes research in order to measure the success of our relationship, as well as exploring collaborations beyond the six disease specialties.
Watch highlights from the event announcing Hartford HealthCare Cancer Institute’s certification in the MSK Cancer Alliance.